ESRX - Express Scripts Holding Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
76.71
+0.19 (+0.25%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close76.52
Open76.66
Bid0.00 x 0
Ask0.00 x 0
Day's Range76.09 - 77.33
52 Week Range55.80 - 85.07
Volume2,142,710
Avg. Volume5,351,019
Market Cap43.075B
Beta1.09
PE Ratio (TTM)9.91
EPS (TTM)7.74
Earnings DateMay 2, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2003-11-12
1y Target Est87.76
Trade prices are not sourced from all markets
  • PR Newswire2 days ago

    "Knowing But Not Doing: The State of Rx Adherence in America Report" Finds Big Difference in What Americans Know and Do When It Comes to Their Chronic Medications

    ST. LOUIS, April 25, 2018 /PRNewswire/ -- Many Americans on medications for chronic diseases are not concerned about missing doses, resent their spouses/partners reminding them to take their medicine and think they do a better job than others at taking their medication as prescribed. The survey found that nearly one-third of those taking prescription medications for chronic conditions say they are not concerned about forgetting to take their medications despite the fact that almost one-half believe it is the most important thing they can do to protect their health. They also don't want to be nagged by their spouse/partner about taking their medicine, rating them as the most annoying source of reminders to take their medicine. Although not concerned if they miss a dose or two, people still give themselves high marks for taking their medication as prescribed, with 54 percent of respondents claiming they do a better job of it than others — this is especially true for people 55 and older (60 percent).

  • Reuters3 days ago

    Express Scripts targets Amgen, Lilly migraine drugs in pricing shift

    The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc (AMGN.O), Eli Lilly and Co (LLY.N) and other makers of new migraine medicines to try and fix it. Express Scripts (ESRX.O) told Reuters it is pressing them to forego the usual strategy of setting a high U.S. list price, then lowering the cost for health plans through hefty rebates. It is also seeking a refund if the drugs don't work within a defined timeframe.The shift could help Express Scripts and other pharmacy benefits managers (PBMs) bring prices down, and deflect growing criticism of their role as "middlemen" in the drug supply chain.

  • Can PBM Unit Boost Express Scripts' (ESRX) Q1 Earnings?
    Zacks3 days ago

    Can PBM Unit Boost Express Scripts' (ESRX) Q1 Earnings?

    Impressive performance by the PBM unit is likely to drive Express Scripts' (ESRX) Q1 earnings.

  • Reuters3 days ago

    Express Scripts targets new migraine drugs to change U.S. pricing dynamic

    The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc and other makers of new migraine medicines to try and fix it. Express Scripts told Reuters it is pressing them to forego the usual strategy of setting a high U.S. list price, then lowering the cost for health plans through hefty rebates. It is also seeking a refund if the drugs don't work within a defined timeframe.The shift could help Express Scripts and other pharmacy benefits managers (PBMs) bring prices down, and deflect growing criticism of their role as "middlemen" in the drug supply chain.

  • Reuters3 days ago

    FOCUS-Express Scripts targets new migraine drugs to change U.S. pricing dynamic

    The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc and other makers of new migraine medicines to try and fix it. Express Scripts told Reuters it is pressing them to forego the usual strategy of setting a high U.S. list price, then lowering the cost for health plans through hefty rebates. The shift could help Express Scripts and other pharmacy benefits managers (PBMs) bring prices down, and deflect growing criticism of their role as "middlemen" in the drug supply chain.

  • Reuters3 days ago

    Glenview's Robbins says talk of Amazon's entering pharma is overblown

    Glenview Capital Management Chief Executive Larry Robbins said on Monday at the Sohn Investment Conference in New York that he still likes a trio of stocks he already owns, citing CVS Health Corp (CVS.N), McKesson Corp (MCK.N) and Express Scripts Holdings (ESRX.O). Amazon has not made significant hires in the pharmacy business and does not have the licenses needed to enter the business, Robbins said. Amazon's entry into the business of selling medications, is "neither imminent, assured, nor likely to succeed," he said.

  • Hedge fund billionaire explains why Amazon won't get into pharma
    Yahoo Finance3 days ago

    Hedge fund billionaire explains why Amazon won't get into pharma

    Amazon hasn't obtained pharamcy licenses to sell pills.

  • Reuters3 days ago

    Glenview's Robbins says talk of Amazon's entering pharma is overblown

    Glenview Capital Management Chief Executive Larry Robbins said on Monday at the Sohn Investment Conference in New York that he still likes a trio of stocks he already owns, citing CVS Health Corp, McKesson Corp and Express Scripts Holdings. Amazon has not made significant hires in the pharmacy business and does not have the licenses needed to enter the business, Robbins said. Amazon's entry into the business of selling medications, is "neither imminent, assured, nor likely to succeed," he said.

  • CNBC3 days ago

    Glenview's Larry Robbins is hot on health care stocks again

    Larry Robbins is bullish on health care again and made a pitch for three companies he likes at this year's Sohn Conference. In keeping with what has been a familiar theme for the founder, CEO and portfolio manager at Glenview Capital Management, Robbins picked Express Scripts ESRX -Cigna CI , CVS CVS -Aetna AET and McKesson MCK as his winners in the field. "These stocks are all trading at historically low multiples," Robbins said during a rapid-fire presentation at the glitzy annual gathering of hedge-fund and investing heavyweights.

  • Reuters3 days ago

    DoJ asks Cigna, Express Scripts for additional information

    Cigna Corp said the U.S. Department of Justice has sought additional information from the company and Express Scripts in connection with the health insurer's ongoing $52 billion takeover of Express Scripts. The request is to extend the waiting period imposed by the HSR Act until 30 days after the companies comply with the request, Cigna said in a filing.

  • Fight against opioids impacts workers' comp spending, myMatrixx report finds
    American City Business Journals4 days ago

    Fight against opioids impacts workers' comp spending, myMatrixx report finds

    Prescription drug costs represent a significant portion of workers’ compensation medical costs.

  • Better Buy: CVS Health Corporation vs. Express Scripts
    Motley Fool5 days ago

    Better Buy: CVS Health Corporation vs. Express Scripts

    Both companies are in the thick of big acquisition deals. But which is the better stock to buy now?

  • Cigna-Express Scripts Deal to Face Justice Department Review
    Bloomberg8 days ago

    Cigna-Express Scripts Deal to Face Justice Department Review

    Cigna Corp. confirmed that its proposed $54 billion acquisition of Express Scripts Holding Co. will be reviewed by the U.S. Department of Justice, which has raised the bar for approving deals that don’t combine direct competitors. Analysts at Credit Suisse sent an alert to clients on April 5, saying Cigna Chief Executive Officer David Cordani told investors during an event in Europe that the deal would be looked at by the Justice Department. Cigna agreed in March to acquire Express Scripts, a pharmacy-benefits manager, wagering that the combination can reduce costs and improve benefits for Americans by simplifying the health-care supply chain.

  • Moody's10 days ago

    Moody's: Healthcare Quarterly looks at credit impact of planned mergers in US healthcare

    In its latest issue of Healthcare Quarterly, Moody's Investors Service examines how planned mergers between health insurers and other healthcare companies, as well as potential new entrants to the US healthcare ...

  • InvestorPlace10 days ago

    UnitedHealth Group Inc Stock: Wall Street’s Biggest Moat

    UnitedHealth Group Inc (NYSE:UNH), the giant health insurer, beat the street on April 17 and raised estimates, illustrating its dominance in the healthcare space. The company earned $2.924 billion, $3.04-per-share fully adjusted, on revenues of $55.188 billion. This handily beat estimates for $2.92-per-share of earnings, and whispers of $2.97-per-share, on revenues of $54.85 billion. The stock rose to $6.04-per-share, 2.69%, in anticipation of earnings, and added another $4.19, 1.82%, in pre-market trading.

  • How Is UNH’s Optum Business Positioned in the Industry?
    Market Realist10 days ago

    How Is UNH’s Optum Business Positioned in the Industry?

    UnitedHealth Group is, by revenue, the largest healthcare company in the world. Its subsidiaries, UnitedHealthcare and Optum, offer health insurance services and healthcare products.

  • TheStreet.com10 days ago

    Here's What to Watch as UnitedHealth Reports Earnings on Tuesday

    The company's underwriting margins and traditional health insurance business are key areas to watch, according to BMO Capital Markets' Matthew Borsch.

  • GlobeNewswire14 days ago

    Express Scripts Holding Company Announces First Quarter 2018 Earnings Release Details

    Louis, April 13, 2018-- Express Scripts Holding Company announced today its intention to release its 2018 first quarter financial results on Wednesday, May 2, 2018, after the market closes. Management ...

  • Express Scripts (ESRX) to Launch Pilot Program, Shares Up
    Zacks14 days ago

    Express Scripts (ESRX) to Launch Pilot Program, Shares Up

    Express Scripts (ESRX) aims to add value to patients' diagnosis in return for higher costs.

  • CNBC15 days ago

    Mallinckrodt shares slide on whistleblower lawsuit involving its best-selling drug

    The lawsuit claims Mallinckrodt continued to raise the price of Acthar despite knowing what was in it.

  • Is Express Scripts Holding Company’s (NASDAQ:ESRX) Balance Sheet Strong Enough To Weather A Storm?
    Simply Wall St.15 days ago

    Is Express Scripts Holding Company’s (NASDAQ:ESRX) Balance Sheet Strong Enough To Weather A Storm?

    Investors seeking to preserve capital in a volatile environment might consider large-cap stocks such as Express Scripts Holding Company (NASDAQ:ESRX) a safer option. Risk-averse investors who are attracted to diversifiedRead More...

  • PR Newswire15 days ago

    Express Scripts Launches Innovative Pilot Program For Performance-based Retail Pharmacy Network for Commercial Plans

    "Pharmacists are one of the most trusted of all healthcare professionals and their frequent interactions with our members present enormous opportunities to positively impact patient health," said Amy Bricker, RPh, President, Supply Chain, Express Scripts.

  • Profit From Record Q1 M&A With These ETFs
    Zacks17 days ago

    Profit From Record Q1 M&A With These ETFs

    Global mergers and acquisitions had their strongest start ever totaling $1.2 trillion in the first quarter of 2018.

  • The Wall Street Journal22 days ago

    Express Scripts Appoints New CIO from Farmers Insurance

    Ron Guerrier, who led the creation of Toyota’s innovation lab before serving as CIO at Farmers Insurance, joins Express Scripts amid the company’s sale to health insurer Cigna.

  • MARKETS: Amazon and Best Buy become new BFFs, Roku stock tanks
    Yahoo Finance Video9 days ago

    MARKETS: Amazon and Best Buy become new BFFs, Roku stock tanks

    Yahoo Finance's Jared Blikre and Alexis Christoforous break down the latest market action after two retail giants join forces to sell a new line of Fire TV Edition televisions. Best Buy will also become an Amazon merchant.